GE HealthCare Technologies (GEHC) CFO logs 948-share tax withholding

Rhea-AI Filing Summary

GE HealthCare Technologies Inc.’s Chief Financial Officer, James Saccaro, reported a routine tax‑related share withholding. On February 1, 2026, 948 shares of common stock were withheld at $78.97 per share to cover tax obligations from vesting restricted stock units. After this transaction, Saccaro beneficially owned 57,646 shares of GE HealthCare Technologies common stock, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SACCARO JAMES

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.01 per share	948	$78.97	$75K

Holdings After Transaction: Common Stock, par value $0.01 per share — 57,646 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/03/2026 - 06:51 PM Learn about SEC filing dates

FAQ

What insider transaction did GEHC’s CFO report on February 1, 2026?

GE HealthCare Technologies’ CFO James Saccaro reported the withholding of 948 common shares on February 1, 2026. The shares were withheld at $78.97 each to cover taxes arising from the vesting of restricted stock units.

Was the GEHC CFO’s Form 4 transaction an open-market stock sale?

No, the transaction was not an open-market sale. It was a withholding of 948 GE HealthCare shares at $78.97 per share to satisfy tax withholding obligations triggered by vesting restricted stock units.

How many GEHC shares were withheld for taxes from the CFO’s award?

A total of 948 GE HealthCare Technologies common shares were withheld. The filing states these shares were retained by the company to meet tax withholding obligations related to the vesting of restricted stock units held by the CFO.

What price per share was used for the GEHC CFO tax withholding?

The tax withholding used a price of $78.97 per GE HealthCare Technologies common share. This price applied to 948 withheld shares in connection with restricted stock units that vested for Chief Financial Officer James Saccaro.

How many GEHC shares does the CFO own after the reported transaction?

After the reported transaction, Chief Financial Officer James Saccaro beneficially owned 57,646 GE HealthCare Technologies common shares. The Form 4 indicates these shares are held directly following the 948-share tax withholding on February 1, 2026.

What was the purpose of the GEHC CFO’s share withholding noted in the Form 4?

The purpose was to satisfy tax withholding obligations. The filing explains that 948 GE HealthCare Technologies shares were withheld to cover taxes due when Saccaro’s restricted stock units vested, rather than representing a discretionary share sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SACCARO JAMES

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/01/2026		F		948(1)	D	$78.97	57,646	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.